Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Lapatinib
Sponsor: Gary Schwartz
Collaborators: University of Colorado, Denver|North Shore University Hospital